Management of Moderate‐to‐Highly Exuding Chronic Leg Ulcers With Superabsorbent Wound Dressings Versus Foams Dressings in Polish Settings: An Early‐Stage Cost‐Effectiveness Evaluation
International Journal of Nursing Practice · 2026-06 · 32 (3)
DOI: 10.1111/ijn.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nursing Practice, online erschienen am 28.04.2026. Verfasst von Vladica Veličković und 3 weiteren Autor:innen. Beteiligte Einrichtung: Evidence Generation Department, Hartmann Group, Heidenheim, Germany. Hauptthemen laut MEDLINE: Leg Ulcer, Cost-Benefit Analysis, Cost-Effectiveness Analysis, Bandages. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Chronic leg ulcers (CLUs) are complex wounds that often fail to heal within a reasonable timeframe, leading to prolonged morbidity, reduced quality of life and significant healthcare costs. The severity and exudate level of these wounds influence treatment choice and patient outcomes. In Poland, evidence on the economic impact of advanced dressings for CLUs remains limited, despite their inclusion in clinical guidelines.
Aim
This study aims to evaluate the cost‐effectiveness and cost‐utility of superabsorbent polymer dressings versus foam dressings in the management of moderate‐to‐highly exuding chronic leg ulcers within Polish healthcare settings.
Methods
This early‐stage model‐based economic evaluation was conducted in a time horizon of 6 months within the context of the Polish healthcare system. The model inputs were identified through systematic literature reviews and incorporated into a mathematical model that accounted for the natural history of chronic leg ulcers.
Results
The average cost per patient for superabsorbent polymer dressings was estimated at PLN 11144 (€2563; $2786), while foam dressings averaged PLN 14685 (€3378; $3671), contributing to the cost difference between the two wound dressings of PLN 3541 (€815; $885) per patient over 6 months. Healing rates are projected to improve by an additional 2%, and health‐related quality of life is expected to increase by 0.123 quality‐adjusted life weeks in favour of superabsorbent polymer dressings.
Conclusion
These results provide evidence that superabsorbent polymer dressings are clinically and economically viable treatment options compared to foams for moderately to excessively exuding chronic leg ulcers in Poland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Evidence Generation Department, Hartmann Group, Heidenheim, Germany.
- Institute of Public Health, Medical Decision Making and HTAUMIT, Hall in Tirol, Austria.
- Medical Center of Postgraduate Education, Warsaw, Poland.
- Antoni Jurasz University Hospital No. 1, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
ORCID-Profile: Vladica Veličković
Zitieren
APA
Veličković, V., Serafin, A., Mrozikiewicz-Rakowska, B., & Jawień, A. (2026). Management of Moderate‐to‐Highly Exuding Chronic Leg Ulcers With Superabsorbent Wound Dressings Versus Foams Dressings in Polish Settings: An Early‐Stage Cost‐Effectiveness Evaluation. International Journal of Nursing Practice, 32(3). https://doi.org/10.1111/ijn.70147
Vancouver
Veličković V, Serafin A, Mrozikiewicz-Rakowska B, Jawień A. Management of Moderate‐to‐Highly Exuding Chronic Leg Ulcers With Superabsorbent Wound Dressings Versus Foams Dressings in Polish Settings: An Early‐Stage Cost‐Effectiveness Evaluation. International Journal of Nursing Practice. 2026;32(3). doi:10.1111/ijn.70147
BibTeX
@article{Velikovi2026,
author = {Veličković, Vladica and Serafin, Anna and Mrozikiewicz-Rakowska, Beata and Jawień, Arkadiusz},
title = {Management of Moderate‐to‐Highly Exuding Chronic Leg Ulcers With Superabsorbent Wound Dressings Versus Foams Dressings in Polish Settings: An Early‐Stage Cost‐Effectiveness Evaluation},
journal = {International Journal of Nursing Practice},
year = {2026},
volume = {32},
number = {3},
doi = {10.1111/ijn.70147}
}
EUVIMED